Sociodemographic Disparities in Colorectal Cancer Biomarker Testing Rates Across the United States
Older age, lower educational level in the area of residence, community-setting treatment, and treatment at East South Central facilities are associated with lower rates of microsatellite instability (MSI) and KRAS biomarker testing in patients with metastatic colorectal cancer.